Newsletter | October 27, 2020

10.27.20 -- Drug Development Insights: Improve Formulation Efficacy, Eliminate Unnecessary Testing

The Pharma Trends You Need To Know: A CDMO’s Perspective
Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.
Strategies For API Solubility And Bioavailability Enhancement: Selecting Technologies And Excipients
Bypassing conventional trial-and-error methods for solubility challenges and excipient selection can eliminate unnecessary testing, improve the efficacy of your formulation, and increase your overall speed-to-market.
Ensuring The Greatest Return From Your Poorly Soluble Molecule
Currently, about 70 percent of new molecular entities exhibit poor solubility in water and require some form of enhancement in order to achieve sufficient bioavailability. However, the sheer number of potential strategies for improving the solubility of a compound can overwhelm many developers, leaving them unsure how to choose a path forward.
Optimize Chemical Synthesis, Formulation In Complex Molecule Development
Finding a balance between a complex API, its formulation, and its synthesis requires equipment, knowledge, and processes more extensive than those typically required for traditional drug development.